[HTML][HTML] Bariatric surgery in patients with non-alcoholic fatty liver disease-from pathophysiology to clinical effects
TL Laursen, CA Hagemann, C Wei… - World journal of …, 2019 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a significant liver
disease, and it covers the disease spectrum from simple steatosis with a risk of development …
disease, and it covers the disease spectrum from simple steatosis with a risk of development …
[HTML][HTML] Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
ABSTRACT CONTEXT AND OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) has
been increasingly diagnosed worldwide and is now recognized as a source of public health …
been increasingly diagnosed worldwide and is now recognized as a source of public health …
Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease
S Qadri, N Ahlholm, I Lønsmann… - The Journal of …, 2022 - academic.oup.com
Context Guidelines recommend blood-based fibrosis biomarkers to identify advanced
nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with …
nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with …
Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study
Background Nonalcoholic fatty liver disease (NAFLD) is common among subjects who
undergo bariatric surgery and its postsurgical improvement has been reported. This study …
undergo bariatric surgery and its postsurgical improvement has been reported. This study …
Impact of weight regain on the evolution of non-alcoholic fatty liver disease after Roux-en-Y gastric bypass: a 3-year follow-up
LS Jimenez, FH Mendonça Chaim… - Obesity surgery, 2018 - Springer
Background The influence of post-surgical weight regain on the course of non-alcoholic fatty
liver disease (NAFLD) is unclear. Objective To evaluate the influence of weight regain on the …
liver disease (NAFLD) is unclear. Objective To evaluate the influence of weight regain on the …
Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta …
SM López Tórrez, CO Ayala, PB Ruggiro… - Frontiers in …, 2024 - frontiersin.org
Introduction A prognostic model to predict liver severity in people with metabolic dysfunction-
associated steatotic liver disease (MASLD) is very important, but the accuracy of the most …
associated steatotic liver disease (MASLD) is very important, but the accuracy of the most …
Systematic review and meta‐analysis: non‐invasive detection of non‐alcoholic fatty liver disease related fibrosis in the obese
Background Non‐alcoholic fatty liver disease (NAFLD) is a significant disease burden in
obesity. Liver fibrosis is an important prognostic factor in NAFLD, and detection is vital. The …
obesity. Liver fibrosis is an important prognostic factor in NAFLD, and detection is vital. The …
Machine learning models for predicting significant liver fibrosis in patients with severe obesity and nonalcoholic fatty liver disease
CH Lu, W Wang, YCJ Li, IW Chang, CL Chen, CW Su… - Obesity Surgery, 2024 - Springer
Purpose Although noninvasive tests can be used to predict liver fibrosis, their accuracy is
limited for patients with severe obesity and nonalcoholic fatty liver disease (NAFLD). We …
limited for patients with severe obesity and nonalcoholic fatty liver disease (NAFLD). We …
Fibroscan-based score to predict significant liver fibrosis in morbidly obese patients with nonalcoholic fatty liver disease
Background The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been
reported in 74 to 90% of morbidly obese patients. This study aims to develop a scoring …
reported in 74 to 90% of morbidly obese patients. This study aims to develop a scoring …
Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives
Nonalcoholic fatty liver disease (NAFLD) is a metabolic complication of obesity that
encompasses a spectrum of conditions, including hepatic steatosis, nonalcoholic …
encompasses a spectrum of conditions, including hepatic steatosis, nonalcoholic …